Stock Events

Stock Events

Nanoform Finland 

SEK5.17
6
+SEK0.18+3.61% Today

Statistics

Day High
5.39
Day Low
5.15
52W High
15.22
52W Low
4.15
Volume
183,169
Avg. Volume
-
Mkt Cap
442.91M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.07
-0.05
-0.04
-0.02
Expected EPS
-0.04924764625
Actual EPS
N/A

Financials

-843.06%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
63.28MRevenue
-533.51MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NANOFS.ST. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap277.02B
Merck KGaA operates in the healthcare sector, offering a range of specialty chemicals, materials, and services for pharmaceutical manufacturing that overlap with Nanoform's nanoparticle engineering for drug development.
DuPont de Nemours
DD
Mkt Cap18.95B
DuPont de Nemours, Inc. offers a variety of materials and solutions for the pharmaceutical industry, including drug delivery technologies that compete with Nanoform's offerings.
Pfizer
PFE
Mkt Cap149.77B
Pfizer Inc., as a large pharmaceutical company, invests in drug delivery and formulation technologies, potentially competing with Nanoform's innovative nanoparticle solutions.
Astrazeneca
AZN.LSE
Mkt Cap209.55B
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its pharmaceutical division Janssen, develops and manufactures drugs that may utilize technologies competing with Nanoform's nanoparticle engineering.
GSK
GSK.LSE
Mkt Cap75.89B
Novo Nordisk
NVO
Mkt Cap194.57B
Novo Nordisk A/S focuses on drug delivery systems for its diabetes and obesity care products, which could compete with Nanoform's nanoparticle formulation technologies.

About

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances. It also offers STARMAP, an online platform to pick winners among candidate molecules for CESS powered nanoforming. The company was founded in 2008 and is headquartered in Helsinki, Finland.
Show more...
CEO
Mr. Albert Alexander Haeggstrom
Employees
171
Country
Finland
ISIN
FI4000330972

Listings

ST
SE
NANOFS.ST
STU
DE
4YL.STU
MU
DE
4YL.MU
HE
FI
NANOFH.HE

0 Comments

Share your thoughts

FAQ

What is Nanoform Finland stock price today?▼
The current price of NANOFS.ST is SEK5.17 SEK — it has increased by +3.61% in the past 24 hours. Watch Nanoform Finland stock price performance more closely on the chart.
What is Nanoform Finland stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nanoform Finland stocks are traded under the ticker NANOFS.ST.
What is Nanoform Finland market cap?▼
Today Nanoform Finland has the market capitalization of 442.91M
When is the next Nanoform Finland earnings date?▼
Nanoform Finland is going to release the next earnings report on May 19, 2026.
What were Nanoform Finland earnings last quarter?▼
NANOFS.ST earnings for the last quarter are -0.21 SEK per share, whereas the estimation was -0.69 SEK resulting in a +69.23% surprise. The estimated earnings for the next quarter are N/A SEK per share.
What is Nanoform Finland revenue for the last year?▼
Nanoform Finland revenue for the last year amounts to 63.28M SEK.
What is Nanoform Finland net income for the last year?▼
NANOFS.ST net income for the last year is -533.51M SEK.
How many employees does Nanoform Finland have?▼
As of May 04, 2026, the company has 171 employees.
In which sector is Nanoform Finland located?▼
Nanoform Finland operates in the Health & Wellness sector.
When did Nanoform Finland complete a stock split?▼
Nanoform Finland has not had any recent stock splits.
Where is Nanoform Finland headquartered?▼
Nanoform Finland is headquartered in Helsinki, Finland.